Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
The company patent portfolio for Cairdac currently features 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This single action is assigned to 1 distinct examiner, LUKJAN, SEBASTIAN X, who is also the busiest examiner for the portfolio. The prosecution is concentrated within 1 distinct art unit.
For a practitioner, this data indicates a very focused interaction with the USPTO. With LUKJAN, SEBASTIAN X managing the 1 busiest examiner pending action, the entire pending portfolio's status is determined by this single case. The alignment of 1 distinct examiner and 1 distinct art unit means there is no diversity in the examining perspectives currently being applied to the company's filings in the Medical Devices & Mechanical Engineering area.
This concentrated activity requires a direct focus on the specific feedback from the distinct examiner. Practitioners should note that the workload is minimal, consisting of only 1 pending office action. The lack of multiple examiners or art units simplifies the monitoring process but increases the significance of the individual examiner's decisions on the company's intellectual property goals. There are no other active cases to provide a comparative baseline for prosecution strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LUKJAN, SEBASTIAN X | 1 | 76.4% | +40.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19199604 | MODULE FOR CALCULATING A CARDIAC RHYTHM SETPOINT FOR AN IMPLANTABLE PACEMAKER CONTROLLED DEPENDING ON THE PATIENT'S ACTIVITY | LUKJAN, SEBASTIAN X | — |
| Art Unit | Apps |
|---|---|
| 3792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19199604 | MODULE FOR CALCULATING A CARDIAC RHYTHM SETPOINT FOR AN IMPLANTABLE PACEMAKER CONTROLLED DEPENDING ON THE PATIENT'S ACTIVITY | LUKJAN, SEBASTIAN X | 3792 | §112 | Non-Final OA | — | Pending | May 06, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCairdac has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sebastian X Lukjan has the most, with 1 of Cairdac's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
